파이프라인

독보적인 생명공학 기업, 에이프로젠

바이오신약

AP20비임상

Primary TargetUndisclosed

PlatformBitargeting
Receptor-Antibody Hybrid

Indication퇴행성 관절염

AP40비임상

Primary TargetCA12

PlatformBitargeting
Receptor-Antibody Hybrid

Indication삼중음성유방암

AP70비임상

Primary TargetCD47

PlatformImmune Checkpoint Blocking Antibody

Indication림프종, 고형암

AP10비임상

Primary TargetCD43

PlatformBispecific Antibody

Indication급성백혈병

AP60비임상

Primary TargetTag72

PlatformBitargeting
Receptor-Antibody Hybrid

Indication대장암